To use this site, please disable the ad blocking feature and reload the page.
This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies.
Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused.
The Yomiuri Shimbun Kobayashi Pharmaceutical Co.’s supplement product Benikoji CholesteHelp
Jiji Press
10:36 JST, June 29, 2024
TOKYO (Jiji Press) — Seventy-six new deaths are suspected of having links with the use of Kobayashi Pharmaceutical Co.’s supplements containing benikoji red rice mold, health ministry officials said Friday.
Previously, the company had reported that five people were suspected of having died after taking a Kobayashi Pharmaceutical benikoji supplement product.
The National Institute of Health Sciences has detected a natural compound called puberulic acid and two other compounds from a benikoji ingredient manufactured between June and August last year. The three compounds are believed to have been created by blue mold that infiltrated the process of cultivating benikoji.
Experiments on rats have shown that puberulic acid causes renal disorder. The ministry is investigating how the other compounds can affect the kidney.
